Evidence map›Paper›PMID 37395113›Full record

ArticleCancer2023

Use of electronic cigarettes among African American cancer survivors.

Christelle E Wharram, Jaclyn M Kyko, Julie J Ruterbusch, Jennifer L Beebe-Dimmer, Ann G Schwartz, Michele L Cote

Abstract read
In one paragraph

Article in Cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christelle E WharramSchool of Medicine, Wayne State University, Detroit, Michigan, USA.
Jaclyn M KykoDepartment of Oncology, School of Medicine, Detroit, Michigan, USA.ORCID 0000-0001-7568-9218
Julie J RuterbuschDepartment of Oncology, School of Medicine, Detroit, Michigan, USA.
Jennifer L Beebe-DimmerDepartment of Oncology, School of Medicine, Detroit, Michigan, USA.ORCID 0000-0002-4320-739X
Ann G SchwartzDepartment of Oncology, School of Medicine, Detroit, Michigan, USA.
Michele L CoteIndiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.ORCID 0000-0003-0312-1601

Funding

Tumor Biology and Microenvironment (Program 1)P30CA022453 · NCI · WAYNE STATE UNIVERSITY · PI PAUL M STEMMER · 1985 to 2026
$68.4M
The impact of the COVID-19 pandemic on African American cancer survivors and their caregiversU01CA199240 · NCI · WAYNE STATE UNIVERSITY · PI Jennifer L Beebe-Dimmer, Ann G. Schwartz · 2017 to 2026
$15.2M
NCI NIH HHS P30 CA022453NCI NIH HHS U01 CA199240
6 · The paper itself

Abstract

backgroundThe use of electronic cigarettes (e-cigarettes) is increasing rapidly in the United States, although the negative health outcomes associated with these products are still unknown. Emerging research has examined the use of e-cigarettes in the cancer survivor population as a whole, yet none has focused on e-cigarette use in the African American (AA) cancer survivor population.

methodsThe authors used data from the Detroit Research on Cancer Survivors cohort study, comprised of AA adult cancer survivors. Logistic regression models were used to evaluate factors potentially associated with e-cigarette ever use and current use.

resultsOf 4443 cancer survivors who completed a baseline interview, 8.3% (n = 370) reported ever using e-cigarettes, and 16.5% (n = 61) of those reporting ever use also reported current use of e-cigarettes. Ever users and current users were on average younger than those who did not use e-cigarettes (57.5 vs. 61.2 years; p < .001). Current cigarette smokers were >20 times more likely (odds ratio, 20.75; 95% confidence interval, 12.84-33.55) and former smokers were almost 10 times more likely (odds ratio, 9.50; 95% confidence interval, 6.03-14.97) to have ever used e-cigarettes than never-smokers. Preliminary data suggested that ever use of e-cigarettes is associated with later stage at diagnosis for breast and colorectal cancers.

conclusionsAs the use of e-cigarettes increases in the general population, it is important to continue to monitor their use in cancer survivors and to gain more insight as it pertains to the AA cancer survivor population. Elucidation of the factors associated with e-cigarette use in this population may help inform comprehensive cancer survivorship recommendations and interventions.

Indexed as

Cancer SurvivorsElectronic Nicotine Delivery SystemsNeoplasmsSmoking CessationAdultBlack or African AmericanCohort StudiesCross-Sectional StudiesHumansUnited StatesAfrican Americanagecancer survivorcigarette smokingelectronic cigarettes (e-cigarettes)

Identifiers

PMID37395113
PMCPMC11556268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.